ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1154

Hispanic Patients with Rheumatoid Arthritis Have Greater Discordance Between Patient and Physician Global Estimates Than Other Ethnic Groups, Explained Largely by Fibromyalgia (FM) According to a FM Assessment Screening Tool 3 (FAST3)

Isabel Castrejon1, Mariam Riad 2, Joel A. Block 1 and Theodore Pincus 2, 1Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Discordance, doctor-patient relationship, health disparities and patient outcomes, Hispanic patients

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Healthcare Disparities In Rheumatology Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Discordance between patient and physician global estimates has been described in many rheumatic diseases, including rheumatoid arthritis (RA)1, and has been associated with decreased work productivity2, greater radiological joint destruction and functional impairment3, and a lower likelihood to be in remission4. The objective of this study was to compare the level of discordance according to self-reported race/ethnicity, and to estimate the level of discordance in patients who met and did not meet criteria for concomitant fibromyalgia (FM) by a FM Assessment Screening Tool (FAST3-P).

Methods: At one site, patients complete a multidimensional health assessment questionnaire/routine assessment of patient index data (MDHAQ/RAPID3) (0-30) as part of routine care, which includes 0-10 scores for physical function, and 0-10 visual analogue scales (VAS) for pain, patient global estimate (PATGL), and fatigue, as well as a 0-60 symptom checklist, and a 0-48 RADAI self-report painful joint count. FAST3-P is a cumulative index based on a 0–3 sum of 1 point each for pain VAS≥6, RADAI self-report joint count≥16, and symptom checklist≥16 (positive screen for FM≥2). The treating rheumatologist completes a RheuMetric checklist including a physician global (DOCGL) and 3 VAS for inflammation (DOCINF), damage (DOCDAM) and distress (DOCSTR). Patients with primary diagnoses of RA (ICD codes) were classified into one of 3 groups based on the difference between DOCGL and PATGL: concordant group (PATGL-DOCGL within ±2/10), negative discordance (DOCGL-PATGL≥2/10), and positive discordance (PATGL-DOCGL≥2/10). Values are reported as medians (standard deviation) and percentages. Comparisons according to self-reported ethnicity groups were performed using ANOVA or Chi2.

Results: The study included 260 RA patients: 38% Whites, 25% Black, 23% Hispanics, and 14% others. Age and sex were similar in the 4 groups. Education level was highest in “others,” (primarily Asian), followed by White, Black and Hispanic patients. Hispanic patients had poorer scores for pain, physical function, fatigue, and RADAI self-reported compared with other groups (p< 0.001) (Table). A higher percentage of Black and Hispanic patients screened positive for FM according to FAST3-P. Higher scores for PATGL with similar scores for DOCGL lead to higher rate of positive PATGL >DOCGL discordance in Hispanic patients versus others. The difference between PATGL-DOCGL was higher in patients with concomitant FM for each group except for “others” (Figure).

Conclusion: Hispanic patients with RA have poor scores on most MDHAQ self-reported measures compared with non-Hispanic Whites or Black despite similar physician assessments, leading to higher positive discordance rates. Concomitant FM in all RA patients may be an important contributor to discordance between DOCGL and PATGL, recognition of which could help improve the quality of care.

References: 1. Arthritis Care Res (Hoboken). 2014;66(6):934-42. 2. Arthritis Res Ther 2016, 18(1):114. 3. J Rheumatol 2014, 41(6):1061-1066. 4. Ann Rheum Dis. 2016;76(4):708-11.


Table_Discordance

Table: Characteristics of patients according to self-reported race/ethnicity and percentage of concordance/discordance in the four groups. H denotes the group with highest value.

Figure: PATGL-DOCGL difference according to FM status


Disclosure: I. Castrejon, None; M. Riad, None; J. Block, Abbvie, 2, ACR, 6, Agios, 7, Daiichi-Sankyo, 7, GlaxoSmithKline Consumer Healthcare, 5, Jannsen, 2, Medivir, 5, Novartis, 2, OARSI, Omeros, 7, Pfizer, 2, TissueGene, 2, Zynerba Pharma, 5; T. Pincus, Helath Services, 7, Medical History Services LLC, 6, 7, 9, Medical history services LLC, 6, 7.

To cite this abstract in AMA style:

Castrejon I, Riad M, Block J, Pincus T. Hispanic Patients with Rheumatoid Arthritis Have Greater Discordance Between Patient and Physician Global Estimates Than Other Ethnic Groups, Explained Largely by Fibromyalgia (FM) According to a FM Assessment Screening Tool 3 (FAST3) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/hispanic-patients-with-rheumatoid-arthritis-have-greater-discordance-between-patient-and-physician-global-estimates-than-other-ethnic-groups-explained-largely-by-fibromyalgia-fm-according-to-a-fm-a/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hispanic-patients-with-rheumatoid-arthritis-have-greater-discordance-between-patient-and-physician-global-estimates-than-other-ethnic-groups-explained-largely-by-fibromyalgia-fm-according-to-a-fm-a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology